Genesis Biotechnology Group
Consortium of vertically integrated companies providing drug discovery, preclinical research, bioanalytical testing, clinical laboratory diagnostics and manufacturing services. Operates multiple research, chemistry, bioanalytical and clinical laboratory facilities supporting assay development, biomarker discovery, preclinical studies, regulated testing and production under accredited and regulatory-compliant frameworks.
Industries
Nr. of Employees
large (251-1000)
Genesis Biotechnology Group
Robbinsville, New Jersey, United States, North America
Products
Molecular diagnostic test panels
Diagnostic panels covering infectious diseases, hereditary genetic tests and oncology biomarkers using PCR, NGS and other molecular platforms.
Specimen collection and transport platforms
Sample collection systems designed to support multiple molecular tests from a single specimen while maintaining analyte detectability.
Laboratory plasticware and disposables
Injection-molded laboratory plastics and disposables manufactured for use in diagnostic and research workflows.
Molecular diagnostic test panels
Diagnostic panels covering infectious diseases, hereditary genetic tests and oncology biomarkers using PCR, NGS and other molecular platforms.
Specimen collection and transport platforms
Sample collection systems designed to support multiple molecular tests from a single specimen while maintaining analyte detectability.
Laboratory plasticware and disposables
Injection-molded laboratory plastics and disposables manufactured for use in diagnostic and research workflows.
Services
End-to-end preclinical support including discovery biology, in vivo pharmacology, GLP toxicology, DMPK, histopathology and study reporting.
GLP and non-GLP bioanalytical assays including LC-MS/MS, immunoassays and qPCR for pharmacokinetic and toxicokinetic studies.
CLIA/CAP-accredited clinical laboratory services offering molecular diagnostics, anatomic pathology and specialized testing panels for infectious disease, oncology and hereditary genetics.
Development and validation of screening assays and execution of high-throughput and ultra-high-throughput screens against large compound collections.
Injection-molded laboratory plastics and disposables produced under ISO 9001-aligned quality systems for laboratory and diagnostic use.
Design, analytical validation and commercialization support for multi-marker diagnostic assays and genetic testing panels.
End-to-end preclinical support including discovery biology, in vivo pharmacology, GLP toxicology, DMPK, histopathology and study reporting.
GLP and non-GLP bioanalytical assays including LC-MS/MS, immunoassays and qPCR for pharmacokinetic and toxicokinetic studies.
CLIA/CAP-accredited clinical laboratory services offering molecular diagnostics, anatomic pathology and specialized testing panels for infectious disease, oncology and hereditary genetics.
Development and validation of screening assays and execution of high-throughput and ultra-high-throughput screens against large compound collections.
Injection-molded laboratory plastics and disposables produced under ISO 9001-aligned quality systems for laboratory and diagnostic use.
Design, analytical validation and commercialization support for multi-marker diagnostic assays and genetic testing panels.
Expertise Areas
- Preclinical contract research (CRO) services
- Molecular diagnostics and clinical laboratory testing
- Biomarker discovery and diagnostic assay development
- Medicinal chemistry and small-molecule process development
Key Technologies
- Polymerase chain reaction (PCR/qPCR)
- Next-generation sequencing (NGS)
- Liquid chromatography–tandem mass spectrometry (LC-MS/MS)
- Immunoassays (ELISA and electrochemiluminescence ECL)
News & Updates
Participation as exhibitor at conferences such as ARVO, AACR, SOT and ASM-Microbe to present research, assays and service offerings.
Publication describing host resistance to viral infection following topical aminoglycoside application; example of research contributions associated with group members.
Peer-reviewed studies reporting electrochemiluminescence assays and assay application to clinical biomarker measurement and clinical-trial sample analysis.
Series of publications and patent applications on arginase inhibitors and related medicinal chemistry and structural biology research.
Multiple acquisitions to grow preclinical chemistry, clinical services and CRO capabilities documented in company press releases.
Participation as exhibitor at conferences such as ARVO, AACR, SOT and ASM-Microbe to present research, assays and service offerings.
Publication describing host resistance to viral infection following topical aminoglycoside application; example of research contributions associated with group members.
Peer-reviewed studies reporting electrochemiluminescence assays and assay application to clinical biomarker measurement and clinical-trial sample analysis.
Series of publications and patent applications on arginase inhibitors and related medicinal chemistry and structural biology research.
Multiple acquisitions to grow preclinical chemistry, clinical services and CRO capabilities documented in company press releases.